CSIMarket
 


Waters Corp  (WAT)
Other Ticker:  
 


Waters's ROA from the fourth quarter of 2018 to the fourth quarter of 2017 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Waters's ROA in the fourth quarter of 2018?
Waters Corp achieved a return on average assets (ROA) of 14.47 % in its fourth quarter of 2018, this is above WAT's average return on assets of 13.63%.
Waters Corps assets during the 12 months ending in the fourth quarter of 2018 are valued at $4 billion

ROA has improved compared to 1.23% in the third quarter of 2018, due to net income growth.

However, within the Healthcare sector 75 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Dec 31 2018 quarter, so far to 414, from total ROA ranking in the third quarter of 2018 at 2266.

What is ROA?


Return On Assets (Dec 31 2018)
IV. Quarter
(Sep 29 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Total Assets Change -29.99 % -21.69 % -16.79 % -6.68 % 14.21 %
Y / Y Net Income Change - 3.61 % 18.1 % 6.06 % -
Net Income (TTM) in million 594 55 51 27 20
Return On Assets (TTM) 14.47 % 1.23 % 1.06 % 0.53 % 0.4 %
WAT's Total Ranking # 414 # 2266 # 2340 # 2630 # 2828
Total Assets (TTM) in million 3,727 4,043 4,158 4,489 5,324
Seq. Total Assets Change -7.81 % -2.76 % -7.39 % -15.68 % 3.13 %
Seq. Net Income Change 31.3 % -9.42 % 39.06 % - -



Return On Assets Company Ranking
Within: No.
Industry # 3
Sector # 76
Overall # 408

Return On Assets Statistics
High Average Low
18.24 %
13.63 %
0.4 %
(Sep. 30, 2009)   (Dec 31 2017)





Financial Statements
Waters's Assets $ 3,727 million WAT's Balance sheet
Waters's Income $ 185 million Quarterly WAT's Income Statement
WAT's Income by Division See WAT's Income by Division



Annual Return On Assets (Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
(Dec 31 2016)
FY 2016
(Dec 31 2015)
FY 2015
(FY 2014)
FY (Dec. 30, 2014)
Y / Y Total Assets Change -29.99 % 14.21 % 9.22 % 10.08 % 8.24 %
Total Assets in million 3,727 5,324 4,662 4,269 3,878
Y / Y Net Income Change 2823.51 % -96.11 % 11.18 % 8.67 % -4.09 %
Net Income in million 594 20 522 469 432
Return On Assets 15.93 % 0.38 % 11.19 % 10.99 % 11.13 %




Comment on WAT's ROA in the fiscal year ending 2018
In the fiscal year 2018 ROA improved to 15.93 % compared to prior year, due to annual net income growth of 2823.51 % to $593.79 million, and due to decline of value in Waters's assets by -29.99 % to $3,727.43 million, compared to $3,727.43 a year before.


More Return On Assets Ratios
WAT's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
WAT's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for WAT's Competitors
Roa for Waters's Suppliers
Return On Assets for WAT's Customers

You may also want to know
WAT's Roi WAT's Inventory Turnover Ratio WAT's Growth Rates WAT's Dividend Comparisons
WAT's Profitability Ratios WAT's Asset Turnover Ratio WAT's Dividend Growth
WAT's Roe WAT's Valuation Ratios WAT's Financial Strength Ratios WAT's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2018, within Healthcare Sector ROA
Purple Biotech Ltd   37.83 %
Nektar Therapeutics  37.80 %
Oramed Pharmaceuticals Inc   35.38 %
Xtl Biopharmaceuticals Ltd   34.82 %
Cv Sciences Inc   33.89 %
Lifemd Inc   33.87 %
Orgenesis Inc   32.63 %
Regenxbio Inc   30.66 %
Icon Plc  29.19 %
Corcept Therapeutics Inc  26.72 %
National Research Corporation  26.67 %
Molecular Templates inc   26.41 %
Abiomed Inc   25.78 %
Regeneron Pharmaceuticals Inc   24.91 %
Idexx Laboratories Inc  24.84 %
Alpha Pro Tech Ltd   23.66 %
Biospecifics Technologies Corp  21.72 %
Fonar Corporation  21.68 %
Chemed Corporation  21.66 %
Enanta Pharmaceuticals Inc  21.54 %
Align Technology inc   20.85 %
Fuse Medical Inc   20.60 %
Strongbridge Biopharma plc  20.19 %
Mettler toledo International Inc   20.01 %
Utah Medical Products Inc  18.88 %
Masimo Corp  18.40 %
United Therapeutics Corporation  18.02 %
Scientific Industries Inc   18.02 %
Biogen Inc   17.75 %
Psychemedics Corp  17.28 %


Date modified: 2023-03-23T12:40:55+00:00


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com